IP Library Granted Patent US 12,622,982
Granted Patent B2
US 12,622,982 · App. 17/571,168 · Granted May 12, 2026

Implants and biodegradable tissue markers

Inventors: Patrick Campbell (Belmont, MA); Amarpreet S. Sawhney (Lexington, MA)
Assignee: INCEPT, LLC
A61K49/0442A61K49/0419A61K51/1244A61L27/50A61L27/52A61L27/58A61L31/145A61L31/148A61L31/18A61K2123/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,622,982
App. No.
17/571,168
Granted
May 12, 2026
Kind
B2
Abstract

Implantable materials may be used in an iatrogenic site. Applications include radioopaque materials for fiducial marking.

Claims (31)

1 . A method for radiation therapy comprising imaging margins of a hydrogel spacer using ultrasound, wherein the hydrogel spacer is at a site between a first tissue location and a second tissue location to increase a distance between the first tissue location and the second tissue location, the site being chosen to decrease radiation at the first tissue location when the second tissue location receives a dose of therapeutic radiation, wherein the hydrogel spacer comprises a polysaccharide.

2 . The method of claim 1 , wherein the polysaccharide is hyaluronic acid.

3 . The method of claim 1 , wherein the hydrogel spacer comprises an ultrasound contrast agent.

4 . The method of claim 1 , wherein the first tissue location is associated with the rectum and the second tissue location is associated with the prostate gland.

5 . The method of claim 1 , wherein the hydrogel spacer is echolucent under ultrasound imaging.

6 . The method of claim 1 , wherein the hydrogel spacer, as placed in the tissue, has a volume between 1 and 40 ml.

7 . The method of claim 1 , wherein the polysaccharide is enzymatically biodegradable.

8 . The method of claim 1 , wherein the polysaccharide is covalently-crosslinked.

9 . The method of claim 1 , wherein the polysaccharide is a glycosaminoglycan.

10 . The method of claim 9 , wherein the glycosaminoglycan is crosslinked with a reactive precursor species having electrophilic functional groups.

11 . The method of claim 1 , wherein the polysaccharide comprises esterified hyaluronic acid.

12 . The method of claim 1 , wherein the hydrogel spacer comprises hydrogel particles.

13 . The method of claim 12 , wherein the hydrogel particles comprise a collection of covalently-crosslinked, biodegradable hydrogel particles comprising the polysaccharide.

14 . The method of claim 13 , wherein the collection of particles is completely biodegradable at a time between about 30 and about 365 days.

15 . The method of claim 12 , wherein the hydrogel particles are formed by a process comprising breaking up a hydrogel polymer matrix.

16 . The method of claim 15 , wherein the hydrogel particles are formed by a process comprising forcing the hydrogel polymer matrix through a mesh.

17 . The method of claim 12 , wherein the hydrogel particles have a size range from 1 micron to 500 microns.

18 . The method of claim 1 , wherein the hydrogel spacer further comprises a linear polymer.

19 . The method of claim 18 , wherein the hydrogel spacer exhibits shear thinning behavior.

20 . The method of claim 18 , wherein the linear polymer comprises polyethylene glycol.

21 . A method for radiation therapy comprising introducing a hydrogel spacer at a site between a first tissue location and a second tissue location using ultrasound, wherein the hydrogel spacer increases a distance between the first tissue location and the second tissue location, the site being chosen to decrease radiation at the first tissue location when the second tissue location receives a dose of therapeutic radiation, wherein the hydrogel spacer comprises a collection of covalently-crosslinked biodegradable hydrogel particles comprising a polysaccharide.

22 . The method of claim 21 , wherein the hydrogel spacer further comprises a linear polymer.

23 . The method of claim 21 , wherein the polysaccharide comprises hyaluronic acid.

24 . A method for radiation therapy comprising imaging a site of a hydrogel spacer comprising a collection of polysaccharide particles that is positioned between a first tissue location and a second tissue location using ultrasound, wherein the hydrogel spacer establishes a distance between the first tissue location and the second tissue location, the site being chosen to decrease radiation at the first tissue location when the second tissue location receives a dose of therapeutic radiation, wherein the hydrogel spacer further comprises a linear polymer in addition to the hydrogel particles.

25 . The method of claim 24 , wherein the polysaccharide particles comprise hyaluronic acid.

26 . The method of claim 24 , wherein the polysaccharide particles are covalently-crosslinked.

27 . The method of claim 24 , wherein the polysaccharide particles are biodegradable.

28 . A method for radiation therapy comprising imaging a site of a hydrogel spacer that is positioned between a first tissue location and a second tissue location using ultrasound, wherein the hydrogel spacer establishes a distance between the first tissue location and the second tissue location, wherein the hydrogel spacer comprises hydrogel particles, wherein the hydrogel particles comprise a glycosaminoglycan that is crosslinked with a reactive precursor species having electrophilic functional groups.

29 . The method of claim 28 , wherein the hydrogel spacer further comprises a linear polymer in addition to the hydrogel particles.

30 . The method of claim 28 , wherein the hydrogel particles are biodegradable.

31 . The method of claim 28 , wherein the glycosaminoglycan is hyaluronic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2025
From: CAMPBELL, PATRICK; SAWHNEY, AMARPREET S.
To: INCEPT, LLC
Reel/Frame 070855/0398 →
Continuity (9)
Continuation 16999703 · Aug 21, 2020
Continuation 16296795 · Mar 8, 2019
Continuation 15613555 · Jun 5, 2017
Continuation 15066707 · Mar 10, 2016
Continuation 14465202 · Aug 21, 2014
Division 13750570 · Jan 25, 2013
Division 12968527 · Dec 15, 2010
Provisional Application 61286450 · Dec 15, 2009
Related Publication 20220125954A1 · Apr 28, 2022
References Cited (292)
US 3640741A · Etes · 1972 [cited by applicant]
US 3865108A · Hartop · 1975 [cited by applicant]
US 3872856A · Clayton · 1975 [cited by applicant]
US 3992562A · Denzinger et al. · 1976 [cited by applicant]
US 4002173A · Manning et al. · 1977 [cited by applicant]
US 4014335A · Arnold · 1977 [cited by applicant]
US 4193813A · Chvapil · 1980 [cited by applicant]
US 4207893A · Michaels · 1980 [cited by applicant]
US 4674488A · Nashef et al. · 1987 [cited by applicant]
US 4703108A · Silver et al. · 1987 [cited by applicant]
US 4706652A · Horowitz · 1987 [cited by applicant]
US 4714074A · Rey et al. · 1987 [cited by applicant]
US 4741872A · DeLuca et al. · 1988 [cited by applicant]
US 4815449A · Horowitz · 1989 [cited by applicant]
US 4826945A · Cohn et al. · 1989 [cited by applicant]
US 4938763A · Dunn et al. · 1990 [cited by applicant]
US 4970298A · Silver et al. · 1990 [cited by applicant]
US 5100992A · Cohn et al. · 1992 [cited by applicant]
US 5160745A · De Luca et al. · 1992 [cited by applicant]
US 5162430A · Rhee et al. · 1992 [cited by applicant]
US 5304595A · Rhee et al. · 1994 [cited by applicant]
US 5324775A · Rhee et al. · 1994 [cited by applicant]
US 5410016A · Hubbell et al. · 1995 [cited by applicant]
US 5499994A · Tihon et al. · 1996 [cited by applicant]
US 5514379A · Weissleder et al. · 1996 [cited by applicant]
US 5529914A · Hubbell et al. · 1996 [cited by applicant]
US 5543441A · Rhee et al. · 1996 [cited by applicant]
US 5550187A · Rhee et al. · 1996 [cited by applicant]
US 5565215A · Gref et al. · 1996 [cited by applicant]
US 5599552A · Dunn et al. · 1997 [cited by applicant]
US 5618563A · Berde et al. · 1997 [cited by applicant]
US 5629008A · Lee · 1997 [cited by applicant]
US 5733316A · Tierney et al. · 1998 [cited by applicant]
US 5752974A · Rhee et al. · 1998 [cited by applicant]
US 5759583A · Iwamoto et al. · 1998 [cited by applicant]
US 5767284A · Sanchika et al. · 1998 [cited by applicant]
US 5827937A · Gerup · 1998 [cited by applicant]
US 5863984A · Doillon et al. · 1999 [cited by applicant]
US 5872191A · Sanchika et al. · 1999 [cited by applicant]
US 5874500A · Rhee et al. · 1999 [cited by applicant]
US 5900245A · Sawhney et al. · 1999 [cited by applicant]
US 5922025A · Hubbard · 1999 [cited by applicant]
US 5932539A · Stupp et al. · 1999 [cited by applicant]
US 6031148A · Hayes et al. · 2000 [cited by applicant]
US 6051248A · Sawhney et al. · 2000 [cited by applicant]
US 6060534A · Ronan et al. · 2000 [cited by applicant]
US 6063061A · Wallace et al. · 2000 [cited by applicant]
US 6066856A · Fishman · 2000 [cited by applicant]
US 6083524A · Sawhney et al. · 2000 [cited by applicant]
US 6110484A · Sierra · 2000 [cited by applicant]
US 6121341A · Sawhney et al. · 2000 [cited by applicant]
US 6129761A · Hubbell · 2000 [cited by applicant]
US 6149931A · Schwartz et al. · 2000 [cited by applicant]
US 6152943A · Sawhney · 2000 [cited by applicant]
US 6165201A · Sawhney et al. · 2000 [cited by applicant]
US 6176871B1 · Pathak et al. · 2001 [cited by applicant]
US 6177095B1 · Sawhney et al. · 2001 [cited by applicant]
US 6177514B1 · Pathak et al. · 2001 [cited by applicant]
US 6179862B1 · Sawhney · 2001 [cited by applicant]
US 6201065B1 · Pathak et al. · 2001 [cited by applicant]
US 6206930B1 · Burg et al. · 2001 [cited by applicant]
US 6210314B1 · Ein-Gal · 2001 [cited by applicant]
US 6214045B1 · Corbitt, Jr. et al. · 2001 [cited by applicant]
US 6224893B1 · Langer et al. · 2001 [cited by applicant]
US 6268405B1 · Yao et al. · 2001 [cited by applicant]
US 6271278B1 · Park et al. · 2001 [cited by applicant]
US 6280772B1 · Pinkus · 2001 [cited by applicant]
US 6306418B1 · Bley · 2001 [cited by applicant]
US 6319260B1 · Yamamoto · 2001 [cited by applicant]
US 6371975B2 · Cruise et al. · 2002 [cited by applicant]
US 6375634B1 · Carroll · 2002 [cited by applicant]
US 6379373B1 · Sawhney et al. · 2002 [cited by applicant]
US 6383344B1 · Miller et al. · 2002 [cited by applicant]
US 6387977B1 · Sawhney et al. · 2002 [cited by applicant]
US 6388047B1 · Won et al. · 2002 [cited by applicant]
US 6413742B1 · Olsen et al. · 2002 [cited by applicant]
US 6426145B1 · Moroni · 2002 [cited by applicant]
US 6436424B1 · Vogel et al. · 2002 [cited by applicant]
US 6475477B1 · Kohn et al. · 2002 [cited by applicant]
US 6479079B1 · Pathak et al. · 2002 [cited by applicant]
US 6509031B1 · Miller et al. · 2003 [cited by applicant]
US 6514534B1 · Sawhney · 2003 [cited by applicant]
US 6544503B1 · Vanderhoff et al. · 2003 [cited by applicant]
US 6545097B2 · Pinchuk et al. · 2003 [cited by applicant]
US 6566406B1 · Pathak et al. · 2003 [cited by applicant]
US 6592859B1 · Bley · 2003 [cited by applicant]
US 6596471B2 · Pathak et al. · 2003 [cited by applicant]
US 6599448B1 · Ehrhard, Jr. et al. · 2003 [cited by applicant]
US 6605294B2 · Sawhney · 2003 [cited by applicant]
US 6624245B2 · Wallace et al. · 2003 [cited by applicant]
US 6632457B1 · Sawhney · 2003 [cited by applicant]
US 6635267B1 · Miyoshi et al. · 2003 [cited by applicant]
US 6639014B2 · Pathak et al. · 2003 [cited by applicant]
US 6656200B2 · Li et al. · 2003 [cited by applicant]
US 6660301B1 · Vogel et al. · 2003 [cited by applicant]
US 6673093B1 · Sawhney · 2004 [cited by applicant]
US 6689148B2 · Sawhney et al. · 2004 [cited by applicant]
US 6703047B2 · Sawhney et al. · 2004 [cited by applicant]
US 6723709B1 · Pressato et al. · 2004 [cited by applicant]
US 6761908B1 · Roreger · 2004 [cited by applicant]
US 6818018B1 · Sawhney · 2004 [cited by applicant]
US 6862470B2 · Burbank et al. · 2005 [cited by applicant]
US 6875841B2 · Sakanoue et al. · 2005 [cited by applicant]
US 6887974B2 · Pathak · 2005 [cited by applicant]
US 6899889B1 · Hnojewyj et al. · 2005 [cited by applicant]
US 6913744B2 · Gokcen · 2005 [cited by applicant]
US 6923986B2 · Pathak et al. · 2005 [cited by applicant]
US 6958212B1 · Hubbell et al. · 2005 [cited by applicant]
US 7009034B2 · Pathak et al. · 2006 [cited by applicant]
US 7025990B2 · Sawhney · 2006 [cited by applicant]
US 7049346B1 · Van Bladel et al. · 2006 [cited by applicant]
US 7129210B2 · Lowinger et al. · 2006 [cited by applicant]
US 7211651B2 · Pathak · 2007 [cited by applicant]
US 7220270B2 · Sawhney et al. · 2007 [cited by applicant]
US RE39713E · Sawhney et al. · 2007 [cited by applicant]
US 7238364B2 · Sawhney et al. · 2007 [cited by applicant]
US 7332566B2 · Pathak et al. · 2008 [cited by applicant]
US 7413752B2 · Sawhney · 2008 [cited by applicant]
US 7473417B2 · Zeltinger et al. · 2009 [cited by applicant]
US 7597882B2 · Pathak et al. · 2009 [cited by applicant]
US 7648713B2 · Sawhney · 2010 [cited by applicant]
US 7655747B2 · Harris · 2010 [cited by applicant]
US 7744913B2 · Noyes · 2010 [cited by applicant]
US 7776063B2 · Sawhney et al. · 2010 [cited by applicant]
US 7790141B2 · Pathak et al. · 2010 [cited by applicant]
US 7914541B2 · Sawhney et al. · 2011 [cited by applicant]
US 7963287B2 · Lanphere · 2011 [cited by examiner]
US 7964217B2 · Harris · 2011 [cited by applicant]
US 8044137B2 · Khosravi et al. · 2011 [cited by applicant]
US 8105622B2 · Sawhney · 2012 [cited by applicant]
US 8257723B2 · Noyes · 2012 [cited by applicant]
US 8383161B2 · Campbell et al. · 2013 [cited by applicant]
US 8410189B2 · Carnahan et al. · 2013 [cited by applicant]
US 8512749B2 · Sawhney et al. · 2013 [cited by applicant]
US 8535705B2 · Pathak et al. · 2013 [cited by applicant]
US 8642085B2 · Cassingham et al. · 2014 [cited by applicant]
US 8685367B2 · Brandom et al. · 2014 [cited by applicant]
US 8734930B2 · Bennett et al. · 2014 [cited by applicant]
US 8795709B2 · Sawhney et al. · 2014 [cited by applicant]
US 8802146B2 · Cassingham et al. · 2014 [cited by applicant]
US 8846022B2 · Carnahan et al. · 2014 [cited by applicant]
US 8852646B2 · Campbell et al. · 2014 [cited by applicant]
US 9023379B2 · Pathak et al. · 2015 [cited by applicant]
US 9186422B2 · Pathak et al. · 2015 [cited by applicant]
US 9308283B2 · Campbell et al. · 2016 [cited by applicant]
US 9393344B2 · Stockman et al. · 2016 [cited by applicant]
US 9498557B2 · Pathak et al. · 2016 [cited by applicant]
US 9669117B2 · Campbell et al. · 2017 [cited by applicant]
US 9789073B2 · Pathak · 2017 [cited by applicant]
US 9789231B2 · Goodrich · 2017 [cited by applicant]
US 9878066B2 · Stockman et al. · 2018 [cited by applicant]
US 11786612B2 · Campbell · 2023 [cited by examiner]
US 20030012734A1 · Pathak et al. · 2003 [cited by applicant]
US 20030105061A1 · Ishikawa et al. · 2003 [cited by applicant]
US 20030194389A1 · Porter · 2003 [cited by applicant]
US 20040086479A1 · Grinstaff et al. · 2004 [cited by applicant]
US 20040086548A1 · St. John et al. · 2004 [cited by applicant]
US 20040094162A1 · Noyes · 2004 [cited by applicant]
US 20040131582A1 · Grinstaff et al. · 2004 [cited by applicant]
US 20040133275A1 · Mansmann · 2004 [cited by applicant]
US 20050033157A1 · Klein et al. · 2005 [cited by applicant]
US 20050036946A1 · Pathak et al. · 2005 [cited by applicant]
US 20050080445A1 · Sawhney et al. · 2005 [cited by applicant]
US 20050226936A1 · Gerup · 2005 [cited by applicant]
US 20060177481A1 · Sawhney · 2006 [cited by applicant]
US 20060193899A1 · Sawhney · 2006 [cited by applicant]
US 20070231366A1 · Sawhney et al. · 2007 [cited by applicant]
US 20070264227A1 · Lutolf et al. · 2007 [cited by applicant]
US 20080033471A1 · Paz et al. · 2008 [cited by applicant]
US 20080114092A1 · Sawhney · 2008 [cited by applicant]
US 20080187568A1 · Sawhney · 2008 [cited by applicant]
US 20080220047A1 · Sawhney et al. · 2008 [cited by applicant]
US 20080281388A1 · Corbitt et al. · 2008 [cited by applicant]
US 20090011038A1 · Seiler et al. · 2009 [cited by applicant]
US 20090053276A1 · Richard · 2009 [cited by applicant]
US 20090117188A1 · Gershkovich et al. · 2009 [cited by applicant]
US 20100104625A1 · Putnam et al. · 2010 [cited by applicant]
US 20110286956A1 · Zhao et al. · 2011 [cited by applicant]
US 20160271267A1 · Lin et al. · 2016 [cited by applicant]
US 20170216487A1 · Sawhney et al. · 2017 [cited by applicant]
US 20170266324A1 · Campbell et al. · 2017 [cited by applicant]
US 20180044280A1 · Zhu et al. · 2018 [cited by applicant]
US 20200277449A1 · De Cola et al. · 2020 [cited by applicant]
CA 2188464 · 1995 [cited by applicant]
DE 4414755A · 1994 [cited by applicant]
EP 1019446B2 · 2011 [cited by applicant]
EP 1996243B1 · 2014 [cited by applicant]
EP 2397164B1 · 2015 [cited by applicant]
EP 2247645B1 · 2017 [cited by applicant]
WO 9425080A1 · 1994 [cited by applicant]
WO 9812274 · 1998 [cited by applicant]
WO 0024387 · 1999 [cited by applicant]
WO 9959501 · 1999 [cited by applicant]
WO 0028919 · 2000 [cited by applicant]
WO 0045792 · 2000 [cited by applicant]
WO 2001085062 · 2001 [cited by applicant]
WO 03031388 · 2003 [cited by applicant]
WO 2006001009 · 2006 [cited by applicant]
WO 2006031358 · 2006 [cited by applicant]
WO 2006031388 · 2006 [cited by applicant]
WO 2006078770 · 2006 [cited by applicant]
WO 2007001926 · 2007 [cited by applicant]
WO 2007005249 · 2007 [cited by applicant]
WO 2010062783 · 2010 [cited by applicant]
Accu-Space(TM), CP Medical Inc, FDA Summary (Year: 2001). [cited by examiner]
Hoffman , MD et al., Use of Saline-Filled Tissue Expanders to Protect the Small Bowel from Radiation, Oncology, pp. 51-54, vol. 12, No. 1. (Year: 1998). [cited by examiner]
Sezeur, MD et al., Small Intestine Protection from Radiation by Means of a Removable Adapted Prosthesis, Excerpta Medica Inc, vol. 178. (Year: 1999). [cited by examiner]
Extended European Search Report from corresponding European Application No. 21203718.8, 8 pages, dated Jan. 28, 2022. [cited by applicant]
Anscher et al., “Combined External Beam Irradiation and External Regional Hyperthermia for Locally Advanced Adenocarcinoma of the Prostate, International Journal of Radiation Oncology Biology Physics”, vol. 37 (5):1059-… [cited by applicant]
Bailey et al., “Synthesis of Polymerized Vesicles with Hydrolyzable Linkages”, Macromolecules, 25:3-11 (1992). [cited by applicant]
Ball et al., “Silicone Implant to Prevent Visceral Damage During Adjuvant Radiotherapy for Retroperitoneal Sarcoma”, The British Journal of Radiology, vol. 63:346-348 (1990). [cited by applicant]
Burnett et al., “The Use of a Pelvic Displacement Prosthesis to Exclude the Small Intestine From the Radiation Field Following Radical Hysterectomy”, Gynecologic Oncology, vol. 79:438-443 (2000). [cited by applicant]
Cheng et al., “Collagen and Injectable Fillers”, Otolaryngologic Clinics of North America, vol. 35(1):73-85 (Feb. 2002). [cited by applicant]
DeSalva et al., “NA22CL Skin Clearance in Humans and Its Relation to Skin Age”, The Journal of Investigative Dermatology, vol. 45(5):315-318 (1965). [cited by applicant]
Dasmahapatra et al., “The Use of a Biodegradable Mesh to Prevent Radiation-Associated Small-Bowel Injury”, Archives of Surgery, vol. 126:366-369 (Mar. 1991). [cited by applicant]
Galeska et al., “Controlled Release of Dexamethasone from PLGA Microspheres Embedded Within Polyacid-Containing PVA Hydrogels”, AAPS Journal, 7(1):E231-E240 (Sep. 2, 2005). [cited by applicant]
Gander et al., “Crosslinked Poly(alkylene Oxides) for the Preparation of Controlled Release Micromatrices”, Journal of Controlled Release, 5:271-283 (1988). [cited by applicant]
Gayet et al, “High Water Content BSA-PEG Hydrogel for Controlled Release Device: Evaluation of the Drug Release Properties”, Journal of Controlled Release, 38:177-184 (1996). [cited by applicant]
Hatiboglu et al., “Application Technique: Placement of a Prostate-Rectum Spacer in Men Undergoing Prostate Radiation Therapy”, BJU International, 1-6 Pages (May 10, 2012). [cited by applicant]
Horak et al., “Hydrogels in Endovascular Embolization. III. Radiopaque Spherical Particles, Their Preparation and Properties”, Biomaterials, vol. 8:142-145 (Mar. 1987). [cited by applicant]
Hoffman et al., “Morbidity After Intraperitoneal Insertion of Saline-Filled Tissue Expanders for Small Bowel Exclusion From Radiotherapy Treatment Fields: A Prospective Four Years Experience With 34 Patients”, The Ameri… [cited by applicant]
Hyon, “Biodegradable Poly(Lactic Acid) Microsphers for Drug Delivery Systems”, Yonsei Medical Journal, 41(6):720-734 (2000). [cited by applicant]
Jayakrishnan et al., “Hydrogel Microspheres from Crosslinked Poly(methyl methacrylate): Synthesis and Biocompatibility Studies”, Bull Mater Sci, vol. 12(1):17-25 (Mar. 1989). [cited by applicant]
Kimura et al., “Injectable Microsphers with Controlled Drug Release for Glaucoma Filtering Surgery”, Investigative Ophthalmology & Visual Science, 33(12): 3436-3441 (Nov. 1992). [cited by applicant]
Lasic et al., “Sterically Stabilized Liposomes*: A Hypothesis on the Molecular Origin of the Extended Circulation Times”, Biochimica et Biophysica Acta, 1070:187-192 (1991). [cited by applicant]
Lin et al., “Hyaluronic Acid-Filled Mammary Implants: An Experimental Study”, Plastic and Reconstructive Surgery, vol. 94(2):306-315 (1994). [cited by applicant]
Lipschitz et al., “Subcutaneous Fluid Administration in Elderly Subjects: Validation of an Under-Used Technique”, JAGS vol. 36(1):6-9 (Jan. 1991). [cited by applicant]
Mathiowitz et al., “Polyanhydride Microspheres as Drug Carriers I. Hot-Melt Microencapsulation”, Journal of Controlled Release 5:13-22 (1987). [cited by applicant]
Mawad, et al., “Synthesis and Characterization of Radiopaque lodine-containing degradable PVA Hydrogels”, Biomacromolecules, 9:263-268 (2008). [cited by applicant]
Mayhew et al., “Characterization of Liposomes Prepared Using a Microemulsifier”, Biochimica et Biophysica Acta, 775:169-174 (1984). [cited by applicant]
Mettler et al., “Prospective Clinical Trial of SprayGel as a Barrier to Adhesion Formation: An Interim Analysis”, The Journal of the American Association of Gynecologic Laparoscopists, 10(3):339-344 (Aug. 2003). [cited by applicant]
Nihant et al., “Polylactide Microparticles Prepared by Double Emulsion-Evaporation”, Journal of Colloid & Interface Science, 173:55-65 (1995). [cited by applicant]
Noyes et al., “Human Collagen Injections to Reduce Rectal Dose During Radiotherapy”, International Journal of Radiation Oncology Biology Physics, vol. 82(5):1918-1922 (2012). [cited by applicant]
Onik, “Image-Guided Prostate Cryosurgery: State of the Art”, Cancer Control, vol. 8(6):522-531 (Dec. 2001). [cited by applicant]
Park, “Enzyme-Digestible Swelling Hydrogels as Platforms for Long-Term Oral Drug Delivery: Synthesis and Characterization”, Biomaterials, 9:435-441 (1988). [cited by applicant]
Pinkawa, Spacer Application For Prostate Cancer Radiation Therapy, Future Oncology, vol. 10(5):851-864 (2014). [cited by applicant]
Prada et al., “Transperineal Injection of Hyaluronic Acid in Anterior Perirectal Fat to Decrease Rectal Toxicity from Radiation Delivered with Intensity Modulated Brachytherapy or Ebrt for Prostate Cancer Patients”, Int… [cited by applicant]
Reddy et al., “Polyurethane Microspheres as Drug Carriers”, Macromolecular Reports, A32(suppls. 5& 6):789-799 (1995). [cited by applicant]
Sasson et al., “Hypodermoclysis an Alternative Infusion Technique”, American Family Physician, vol. 64(9):1575-1578 (Nov. 1, 2001). [cited by applicant]
Spearman et al., “The Site of Deposition and Rate of Clearance of Saline After Subcutaneous Injection Into the Mouse Tail”, The Journal of Investigative Dermatology, vol. 46(3):251-253 (1966). [cited by applicant]
Sugarbaker et al., “Intrapelvic Prosthesis to Prevent Injury of the Small Intestine With High Dosage Pelvic Irradiation”, Surgery, Gynecology & Obstetrics, vol. 157:269-271 (Sep. 1983). [cited by applicant]
Tabata et al., “Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres”, Pharmaceutical Research, 10(4):487-496 (1993). [cited by applicant]
Torchilin et al., “Liposome-Polymer Systems. Introduction of Liposomes into a Polymer Gel and Preparation of the Polymer Gel Inside a Liposome,” Polymer Science U.S.S.R., 30(10):2307-2312 (1988). [cited by applicant]
Trachtenberg et al., “Prostate Cancer: 11. Alternative Approaches and the Future of Treatment”, Canadian Medical Association, vol. 160(4):528-534 (1999). [cited by applicant]
Supplementary European Search Report from corresponding PCT Application No. PCT/US2010/060474, 10 pages, dated Jul. 15, 2013. [cited by applicant]
Devereux et al., “Protection From Radiation Enteritis by an Absorbable Polyglycolic Acid Mesh Sling”, Surgery, 123-129, (Jun. 6, 1986). [cited by applicant]
Duranti et al., “Injectable Hyaluronic Acid Gel for Soft Tissue Augmentation”, Dermatol Surgery, vol. 24:1317-1325 (1998). [cited by applicant]
“Summary Accu-Space”, CP Medical, Inc., FDA summary, Sep. 4, 2001, 4 pages. [cited by applicant]
Bagshaw et al., “Linear Accelerator Supervoltage Radiotherapy”, Department of Radiology, Stanford University School of Medicine, Jul. 1965, pp. 121-129, vol. 85. [cited by applicant]
Bagshaw et al., “External Beam Radiation Therapy of Primary Carcinoma of the Prostate”, Cancer, August Supplement 1975, pp. 723-728, vol. 36. [cited by applicant]
Berry et al., “Basic Concepts in Radiobiology: A Review”, Therapeutic Radiology, New Directions in Therapy, 1982, pp. 1-15, Medical Examination Publishing Co., Inc. (USA). [cited by applicant]
Bentel, Radiation Therapy Planning, Second Edition, Chapter 13: Treatment Planning—Pelvis, 1992, pp. 439-481, Macmillan Publishing Company. [cited by applicant]
Cherr et al., “Rectouretheral Fistula and Massive Rectal Bleeding from Iodine-125 Prostate Brachytherapy: A Case Report”, The American Surgeon, Feb. 2001, p. 131-134, vol. 67. [cited by applicant]
Clough et al., “Laparoscopic Unilateral Ovarian Transposition prior to Irradiation”, Cancer, Jun. 15, 1996, p. 2638-2645, vol. 77, No. 12. [cited by applicant]
Damin et al., “Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options”, World J Gastroenterol, Jan. 28, 2014, pp. 877-887, Baishideng Publishing Group Co. [cited by applicant]
D'Aangioet al., “Protection of Certain Structures from High Doses of Irradiation”, Department of Radiation Therapy, Sep. 1974, pp. 103-108. [cited by applicant]
Del Regato, “Radiotherapy in the Conservative Treatment of Operable and Locally Inoperable Carcinoma of the Prostate”, Radiology, Apr. 1967, pp. 761-766. [cited by applicant]
Denmeade et al., “A history of prostate cancer treatment”, Nat Rev Cancer. Author manuscript, May 2002, 19 pages. [cited by applicant]
Dicker et al., “Basic Advance Techniques in Prostate Brachytherapy”; Introduction, 2005, 3 pages, Martin Dunitz, Taylor & Francis Group plc (United Kingdom). [cited by applicant]
Emami et al., “Tolerance of Normal Tissue to Therapeutic Irradiation”, Int J. Radiation Oncology Biol. Phys., May 15, 1991, pp. 109-122, vol. 21. [cited by applicant]
Fajardo, Principles and Practice of Radiation Oncology (Third Edition), Chapter 4, Morphology of Radiation Effects on Normal Tissues, 1997, pp. 143-154. [cited by applicant]
George et al., “Cobalt-60 Telecurietherapy in the Definitive Treatment of Carcinoma of the Prostate: A Preliminary Report”, Jul. 23, 1964, pp. 102-109, The United States Naval Hospital (San Diego, California). [cited by applicant]
Hoffman et al., “Use of Saline-Filled Tissue Expanders to Protect the Small Bowel from Radiation”, Oncology, Jan. 1998, pp. 51-54, vol. 12, No. 1. [cited by applicant]
Jemal et al., “Cancer Statistics, 2002”, CA Cancer J Clin, Jan./Feb. 2002, pp. 23-47, vol. 52. No 1. [cited by applicant]
Johnston et al., “Radiation-Induced Pulmonary Fibrosis: Examination of Chemokine Receptor Families”, 2002, pp. 256-265, Radiation Research Society. [cited by applicant]
Jordan et al., “Major Rectal Complications Following Interstitial Implantation of 125 Iodine for Carcinoma of the Prostate”, The Journal of Urology, 1985, pp. 1212-1214. [cited by applicant]
Kennedy et al., “Successful and Sustained Treatment of Chronic Radiation Proctitis With Antioxidant Vitamins E and C”, The American Journal Of Gastroenterology, Apr. 2001, pp. 1080-1084, vol. 96, No. 4. [cited by applicant]
Kettle et al., “Absorbable synthetic versus catgut suture material for perineal repair”, Cochrane Database Syst Rev. Author manuscript, Sep. 15, 2014, pp. 1-18. [cited by applicant]
Khan, The Physics of Radiation Therapy, 2nd ed., Chapter 9: Dose Distribution and Scatter Analysis, 1992, 4 p. pp. 185-186 & 436. [cited by applicant]
Konemann et al., “Fractionated perioperative high dose rate brachytherapy using a tissue equivalent bendy applicator”, The British Journal of Radiology, May 2002, pp. 453-459. [cited by applicant]
Kuban et al., “Hazards of Dose Escalation in Prostate Cancer Radiotherapy”, I. J. Radiation Oncology, No. 5, 2003, pp. 1260-1268, vol. 57. [cited by applicant]
Langley et al., “Prostate brachytherapy has come of age: a review of the technique and results”, BJU International, 2002, pp. 241-249. [cited by applicant]
Lee et al., “Postimplant Analysis of Transperineal Interstitial Permanent Prostate Brachytherapy: Evidence for a Learning Curve in the First Year at a Single Institution”, Int. J. Radiation Oncology, 2000, pp. 83-88, vo… [cited by applicant]
Lee et al., “Lateral Rectal Shielding Reduces Late Rectal Morbidity Following High Dose Three-Dimensional Conformal Radiation Therapy for Clinically Localized Prostate Cancer: Further Evidence for a Significant Dose Eff… [cited by applicant]
Minsky, “Carcinoma of the Esophagus Part 1: Primary Therapy”, Oncology, Sep. 1999, 1225-1232 & 1235-1236, vol. 13, No. 9. [cited by applicant]
Moerland et al., “Evaluation of Permanent I-125 Prostate Implants Using Radiography and Magnetic Resonance Imaging”, I. J. Radiation Oncology, 1997, pp. 927-933, vol. 37, No. 4. [cited by applicant]
Portelance et al., “Intensity-Modulated Radiation Therapy (IMRT) Reduces Small Bowel, Rectum and Bladder Doses in Patients with Cervical Cancer Receiving Pelvic and Para-Aortic Irradiation”, Int. J. Radiation Oncology, … [cited by applicant]
Potters, Basic and Advanced Techniques in Prostate Brachytherapy, Chapter 47: Rectal complications following permanent seed implants, 2005, 8 pages, Martin Dunitz Ltd. (United Kingdom). [cited by applicant]
Reddy et al., Therapeutic Radiology: New Directions in Therapy, Chapter II: Carcinoma of the Prostate, 1983, 40 pages, Medical Examination Publishing Co., Inc. (New Hyde Park, New York). [cited by applicant]
Sauer, “Adjuvant and Neoadjuvant Radiotherapy and Concurrent Radiochemotherapy for Rectal Cancer”, Pathology Oncology Research, 2002, 11 pages, vol. 8, No. 1. [cited by applicant]
Sezeur et al., “ Small Intestine Protection from Radiation by Means of a Removable Adapted Prosthesis”, The American Journal of Surgery, Jul. 1999, pp. 22-25, vol. 178. [cited by applicant]
Shipley et al., “Advanced Prostate Cancer: The Results of a Randomized Comparative Trial of High Dose Irradiation Boosting with Conformal Protons Compared with Conventional Dose Irradiation Using Photons Alone”, I. J. R… [cited by applicant]
Tadavarthy et al., “Polyvinyl Alcohol (Ivalon)—A New Embolic Material”, Department of Radiology, University of Minnesota Hospitals, Nov. 1975, pp. 609-616, vol. 125, No. 3. [cited by applicant]
Yoon et al., “Surgical Treatment and Other Regional Treatments for Colorectal Cancer Liver Metastases”, The Oncologist, 1999, pp. 197-208. [cited by applicant]
Waddell et al., “Absorbable Mesh Sling Prevents Radiation-Inducted Bowel Injury During “Sandwich” Chemoradiation for Rectal Cancer”, Arch Surg., Oct. 2000, pp. 1212-1217. [cited by applicant]
Waddell et al., “Prevention of Chronic Radiation Enteritis”, J Am Coll Surg., 1999, pp. 611-624. [cited by applicant]
Warren et al., “Evaluation of Trends in the Cost of Initial Cancer Treatment”, J Natl Cancer Inst, Jun. 18, 2008, pp. 888-897, vol. 100, Issue 12. [cited by applicant]
Wust et al., “Hyperthermia in combined treatment of cancer”, The Lancet Oncology, Aug. 2002, pp. 487-97, vol. 3. [cited by applicant]
Verpaele et al., “Restylane SubQ, a Non-Animal Stabilized Hyaluronic Acid Gel for Soft Tissue Augmentation of the Mid- and Lower Face” Aesthetic Surgery Journal, Jan. 2006, pp. S10-S17, vol. 26, No. 1 Supplement. [cited by applicant]
Edwards et al., “Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers” Clin Interv Aging, 2007, 2(4):509-519. [cited by applicant]
Flynn et al., “Comparative Histology of Intradermal Implantation of Mono and Biphasic Hyaluronic Acid Fillers” Dermatol Surg., May 2011, 37(5):637-643. [cited by applicant]
Summary of Safety and Effectiveness Data, Injectable Dermal Filler, 2003, 13 pages. [cited by applicant]